News Focus
News Focus
Followers 1
Posts 131
Boards Moderated 0
Alias Born 03/26/2013

Re: None

Thursday, 04/25/2013 4:59:51 PM

Thursday, April 25, 2013 4:59:51 PM

Post# of 724
Note today from Lerink Swann

Related to patent. "We believe the notice of allowance increased the value for PATH's NP201 asset and may be attractive for a potential partner. Once issued the patent will provide protection into July 2028. We continue to expect a 4Q13 launch of Zecurity, and PATH to close a commercial US partnership deal for that product near term....Zecurity is FDA-approved with a good label and Orange Book listed patents until 2029 should be attractive features for a potential partner or acquirer. Given that PATH's current enterprise value is only ~$85MM we believe an outright acquisition of the company coudl be an alternative to a partnership.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PATH News